Epirubicin-based chemotherapy as adjuvant treatment for poor prognosis, node-negative breast cancer: 10-year follow-up results of the French Adjuvant Study Group 03 trial.

Bulletin du cancer

Volumn 93, Issue 10, 2006, Pages

  Héry, Michel ^a   Bonneterre, Jacques ^a   Roché, Henri ^a   Luporsi, Elisabeth ^a   Kerbrat, Pierre ^a   Namer, Moïse ^a   Fumoleau, Pierre ^a   Monnier, Alain ^a   Fargeot, Pierre ^a  

^a CENTRE HOSPITALIER PRINCESSE GRACE   (Monaco)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; EPIRUBICIN; FEC PROTOCOL; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST TUMOR; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MASTECTOMY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; CYCLOPHOSPHAMIDE; EPIRUBICIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MASTECTOMY; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 33750701796     PISSN: None     EISSN: 17696917     Source Type: Journal    
DOI: None     Document Type: Article

References (0)